Epilepsy: open trials in Hungary

12 open trials have a site in Hungary. Registry data; only the trial team decides who can take part.

NCT05716100
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Trial Treatment · Phase 3 · Xenon Pharmaceuticals Inc.
Semmelweis University, Budapest XIV
Registry updated 2026-11-02
NCT05718817
An Open-label Study of XEN1101 in Epilepsy
Trial Treatment · Phase 3 · Xenon Pharmaceuticals Inc.
Semmelweis University, Budapest XIV
Registry updated 2026-11-02
NCT04462770
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Trial Treatment · Phase 3 · Epygenix
Semmelweis University, Budapest · University of Debrecen, Debrecen
Registry updated 2026-10-29
NCT07141329
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Trial Treatment · Phase 2 · Supernus Pharmaceuticals, Inc.
Article 11 CTR HU, DO NOT EDIT
Registry updated 2026-10-27
2024-514499-42-00
Efficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures
Trial Treatment · Phase 3 · Neuraxpharm Pharmaceuticals S.L.
Semmelweis University, Budapest · Semmelweis University, Budapest XIV · Heves Varmegyei Markhot Ferenc Oktatokorhaz Es Rendelointezet, Eger
Registry updated 2026-10-13
NCT05066217
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
Trial Treatment · Phase 3 · Epygenix
Debreceni Egyetem Klinikai Kozpont Nagyerdei Campus, Debrecen
Registry updated 2026-10-09
NCT06798896
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Trial Treatment · Phase 2 · Supernus Pharmaceuticals, Inc.
SE, Idegsebeszeti es Neurointervencios Klinika, Epilepszia Centrum, Budapest · Flash Clinic, Budapest
Registry updated 2026-10-01
2025-520587-18-00
SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures
Trial Treatment · Phase 2 · Supernus Pharmaceuticals Inc.
Flash Clinic LLC, Budapest · Semmelweis University, Budapest XIV
Registry updated 2026-09-02
NCT04715646
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Trial Treatment · Phase 3 · UCB Biopharma SRL
Ep0156 210, Budapest · Ep0156 247, Budapest · Ep0156 232, Miskolc
Registry updated 2026-07-27
NCT06443463
Long-term Safety and Tolerability of BHV-7000
Trial Treatment · Phase 2 · Biohaven Therapeutics Ltd.
Budapesti Bajcsy-Zsilinszky Korhaz Es Rendelointezet, Budapest · Semmelweis University, Budapest XIV · University of Debrecen, Debrecen · University of Pecs, Pécs
Registry updated 2026-05-01
NCT05219617
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Trial Treatment · Phase 3 · SK Life Science, Inc.
Orszagos Mentalis, Ideggyogyaszati es Idegsebezeti Intezet, Budapest · Semmelweis Egyetem Idegsebeszeti és Neurointervencios Klinika, Budapest
Registry updated 2025-07-24
NCT07041619
Subcutaneous Intersectional Short Pulse Stimulation in Epileptic Patients
Trial Treatment · Semmelweis University
Semmelweis University Neurosurgery and Neurointerventional Clinic, Budapest
Registry updated 2025-07-03

All Epilepsy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error